NASEPI

View On IPO.GOV.UK

Withdrawn

on 8 Mar 2021

Last Applicant/ Owned by

Amphastar Pharmaceuticals, Inc.

11570 Sixth St., Rancho Cucamonga

California, , 91730

Serial Number

UK00003606234 filed on 8^th Mar 2021

Correspondent Information

Reddie & Grose LLP

The White Chapel Building, 10 Whitechapel High Street

London,

E1 8QS

NASEPI

pharmaceutical preparations containing epinephrine for the treatment of an emergency or critical care situation, namely the treatment of type i hypers Read More

Classification Information

Class [5]
Pharmaceutical Products

Pharmaceutical preparations containing epinephrine for the treatment of an emergency or critical care situation, namely the treatment of Type I hypersensitivity reactions, through intranasal administration; Nasal spray preparations containing epinephrine for the treatment of Type I hypersensitivity reactions.

Mark Details

Serial Number

UK00003606234

Mark Type

Word

Kind of mark

Individual

NASEPI

Classification Information

Class [5]Pharmaceutical Products

Mark Details

Serial Number

Mark Type

Kind of mark

Class [5]
Pharmaceutical Products